Company Filing History:
Years Active: 2020
Title: The Innovative Mind of James N. Ingle
Introduction: James N. Ingle, an accomplished inventor based in Rochester, MN, has made significant contributions to the field of medical research. With a focus on developing methods and materials for treating estrogen receptor-positive breast cancer, Ingle's work holds promise for improving patient outcomes.
Latest Patents: James N. Ingle holds a patent for "Methods and materials for treating estrogen receptor positive breast cancer." This patent outlines innovative techniques for identifying individuals with this specific type of cancer by determining genetic variants such as the A→G variant genotype of rs6990851. In addition, the patent discusses the use of aromatase inhibitors, like anastrozole, to treat those identified as having an elevated level of CSMD1 nucleic acid expression.
Career Highlights: Ingle's career is highlighted by his affiliation with the Mayo Foundation for Medical Education and Research, a respected institution in the medical field. His research endeavors focus on advancing cancer treatment methods, demonstrating a commitment to enhancing the lives of cancer patients through innovative therapies.
Collaborations: Throughout his career, Ingle has collaborated with esteemed colleagues such as Tanda T. Dudenkov and Liewei Wang. These collaborations have likely helped foster an environment of innovation and creativity, allowing for the development of impactful solutions in cancer treatment.
Conclusion: James N. Ingle exemplifies the spirit of innovation in the medical research community. His dedication to identifying and treating estrogen receptor-positive breast cancer showcases his commitment to improving healthcare. As research continues to evolve, Ingle's contributions will undoubtedly remain influential in the fight against cancer.